Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Transplant Proc ; 50(3): 750-753, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29661429

ABSTRACT

INTRODUCTION: Chronic kidney disease can lead to dysfunction of the respiratory, cardiac, and musculoskeletal systems, altering the body's metabolism. Renal transplantation and hospital physiotherapy, through specific protocols, can improve these dysfunctions. OBJECTIVES: This study evaluates the impact of a hospital physiotherapeutic protocol in quality of life (QoL), respiratory muscle strength, peak expiratory flow, and 6-minute walk test (6MWT) in the preoperative, first, and fifth days after renal transplantation. METHODS: We evaluated 39 patients who received a renal transplant at Clinics Hospital of University of Campinas for respiratory muscle strength, expiratory peak flow, and functional capacity by the 6MWT. The short form-36 quality of life questionnaire was applied to 12 patients. RESULTS: We observed a significant reduction in respiratory muscle strength and peak expiratory flow in the first postoperative day. On postoperative day 5, there was improvement in respiratory muscle strength and expiratory peak flow. However, aerobic capacity measured by 6MWT remained below predicted. Analysis of QoL showed an improvement in almost all analyzed domains after transplantation. CONCLUSION: A specific physiotherapeutic protocol applied early after transplantation provided recovery of respiratory muscle strength and QoL. However, longer training is necessary to obtain adequate aerobic rehabilitation.


Subject(s)
Exercise Tolerance/physiology , Kidney Transplantation/rehabilitation , Quality of Life , Renal Insufficiency, Chronic/physiopathology , Respiration , Aged , Female , Humans , Male , Middle Aged , Muscle Strength/physiology , Postoperative Period , Renal Insufficiency, Chronic/rehabilitation , Renal Insufficiency, Chronic/surgery , Respiratory Function Tests , Respiratory Muscles/physiopathology , Surveys and Questionnaires , Treatment Outcome , Walk Test
2.
Transplant Proc ; 49(4): 813-816, 2017 May.
Article in English | MEDLINE | ID: mdl-28457401

ABSTRACT

BACKGROUND: Aldosterone is involved in the process of renal allograft fibrosis, clinically manifest by proteinuria and allograft dysfunction, with increased risk for cardiovascular death. The treatment with aldosterone antagonists appears to be effective in controlling proteinuria, with a protective effect on progression of renal fibrosis. METHODS: This retrospective, cohort study included kidney transplant recipients from January 1993 to June 2015. Inclusion criteria were persistent proteinuria >0.5 g/d, longer than 6 months, and spironolactone therapy. RESULTS: One hundred forty transplant recipients fulfilled the inclusion criteria and were divided into 3 groups, according to proteinuria levels at the beginning of spironolactone therapy: low (<1 g/24 h), intermediate (1-3 g/24 h), and nephrotic (>3 g/24 h). Groups were comparable in demographic data, with a higher incidence of living related donors in the nephrotic group. In patients with proteinuria ≥1 g/d, we observed a significant reduction in proteinuria after 6 months of therapy that persisted over time. Blood pressure and glomerular filtration rate persisted stable over time. Adverse events were not severe to withdrawal therapy. CONCLUSIONS: Spironolactone can be a safe alternative to control post-transplant proteinuria, especially in patients with mild to moderate allograft dysfunction with proteinuria ≥1 g/day.


Subject(s)
Diuretics/therapeutic use , Kidney Transplantation/adverse effects , Proteinuria/drug therapy , Spironolactone/therapeutic use , Adult , Female , Humans , Male , Middle Aged , Proteinuria/etiology , Retrospective Studies
3.
Transplant Proc ; 49(4): 817-820, 2017 May.
Article in English | MEDLINE | ID: mdl-28457402

ABSTRACT

BACKGROUND: Renal transplant is the therapy of choice for patients with chronic renal disease. In recent years, improvement in immunosuppressive drugs reduced early graft loss associated with acute rejection. However, vascular thrombosis, accounting for 5% of early graft loss, can sensitize the recipient for human leukocyte antibodies, reducing the chance for a second transplant. The aim of this study was to identify risk factors for vascular thrombosis in a single transplant center, to design specific prevention protocol. METHODS: This was a retrospective, case-control study. From the Renal Transplant Unit database, we identified 21 cases of vascular thrombosis in recipients of kidneys from deceased donors. Recipients from the contralateral kidney from the same donor, without vascular complications, were assigned to the control group. Data analyzed included donor, recipient, transplant surgery, and post-operative follow-up. The local ethics committee approved the protocol. RESULTS: Thrombosis and control groups were comparable for recipient characteristics, cold ischemia time, organ side (right or left), and site of arterial anastomosis. We observed an increased risk for vascular thrombosis in kidneys with multiple veins (odds ratio, 11.32; P = .03). Organ retrieval surgery complications, such as vascular lesions or heterogeneous perfusion, despite normal pre-implantation biopsy, were considered risk factors for vascular thrombosis within the first post-operative day (odds ratio, 7.1; P = .03). CONCLUSIONS: In this series, multiple renal vein and organ retrieval surgery complications were risk factors for early vascular thrombosis.


Subject(s)
Kidney Transplantation/adverse effects , Thrombosis/epidemiology , Thrombosis/etiology , Tissue and Organ Harvesting/adverse effects , Adult , Case-Control Studies , Cold Ischemia/adverse effects , Female , Humans , Kidney Failure, Chronic/surgery , Male , Middle Aged , Retrospective Studies , Risk Factors , Tissue Donors
4.
Transplant Proc ; 46(6): 1710-2, 2014.
Article in English | MEDLINE | ID: mdl-25131018

ABSTRACT

The impact of borderline rejection in renal graft remains controversial. The aim of this study was to analyze the presence of C4d deposits in peritubular capillaries and macrophage infiltration in renal biopsies with diagnosis of borderline rejection ant its effect on graft function. Thirty-one renal transplant recipients with a diagnosis of borderline rejection were included. Initial and sequential biopsies were analyzed for morphology, C4d, and macrophage staining and compared with clinical data. Initial biopsies showed 12 samples to be C4d positive, associated with a higher incidence of delayed graft function, earlier post-transplantation time, higher acute tubular necrosis score, capillaritis, and glomerular macrophage infiltration, and a lower level of tubulitis, interstitial fibrosis, and tubular atrophy compared with the C4d-negative samples. In sequential biopsies, 5 patients from the negative group turned C4d positive. Patients with ≥1 positive C4d biopsy (n = 17) showed lower renal graft function at 6 months (1.8 ± 0.8 vs 1.4 ± 0.5 mg/dL; P < .01), 1 year (2.1 ± 1 vs 1.5 ± 0.5 mg/dL; P < .01), and 2 years (2.3 ± 1.3 vs 1.5 ± 0.7 mg/dL; P < .05) of follow-up. The expression of C4d in peritubular capillaries of renal biopsies classified as borderline rejection was associated with a worse prognosis for the renal allograft.


Subject(s)
Complement C4b/metabolism , Delayed Graft Function/metabolism , Kidney Transplantation , Kidney/metabolism , Adult , Biomarkers/metabolism , Biopsy , Capillaries/metabolism , Female , Graft Rejection/metabolism , Humans , Kidney/pathology , Kidney Tubules/blood supply , Kidney Tubules/pathology , Macrophages/metabolism , Male
5.
Transplant Proc ; 46(6): 1757-9, 2014.
Article in English | MEDLINE | ID: mdl-25131029

ABSTRACT

INTRODUCTION: Urinary tract infection (UTI) is the most common infection posttransplant. However, the risk factors for and the impact of UTIs remain controversial. The aim of this study was to identify the incidence of posttransplant UTIs in a series of renal transplant recipients from deceased donors. Secondary objectives were to identify: (1) the most frequent infectious agents; (2) risk factors related to donor; (3) risk factors related to recipients; and (4) impact of UTI on graft function. PATIENTS AND METHODS: This was a retrospective analysis of medical records from renal transplant patients from January to December 2010. Local ethics committee approved the protocol. RESULTS: The incidence of UTI in this series was 34.2%. Risk factors for UTI were older age, (independent of gender), biopsy-proven acute rejection episodes, and kidneys from deceased donors (United Network for Organ Sharing criteria). For female patients, the number of pretransplant pregnancies was an additional risk factor. Recurrent UTI was observed in 44% of patients from the UTI group. The most common infectious agents were Escherichia coli and Klebsiella pneumoniae, for both isolated and recurrent UTI. No difference in renal graft function or immunosuppressive therapy was observed between groups after the 1-year follow-up. CONCLUSIONS: In this series, older age, previous pregnancy, kidneys from expanded criteria donors, and biopsy-proven acute rejection episodes were risk factors for posttransplant UTI. Recurrence of UTI was observed in 44%, with no negative impact on graft function or survival.


Subject(s)
Escherichia coli Infections/etiology , Kidney Transplantation , Klebsiella Infections/etiology , Klebsiella pneumoniae , Postoperative Complications/etiology , Urinary Tract Infections/etiology , Adult , Escherichia coli Infections/epidemiology , Female , Graft Survival , Humans , Incidence , Klebsiella Infections/epidemiology , Male , Middle Aged , Outcome Assessment, Health Care , Postoperative Complications/epidemiology , Recurrence , Retrospective Studies , Risk Factors , Urinary Tract Infections/epidemiology
6.
Transplant Proc ; 44(8): 2260-7, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23026569

ABSTRACT

INTRODUCTION: The organ shortage for transplantation, the principal factor that increases waiting lists, has become a serious public health problem. In this scenario, the intensivist occupies a prominent position as one of the professionals that first has a chance to identify brain death and to be responsible for the maintenance of the potential deceased donor. OBJECTIVE: This report attempts to establish guidelines for care and maintenance of adult deceased donor organs guiding and standardizing care provided to patients with brain death. METHOD: These guidelines were composed by intensivists, transplant coordinators, professionals from various transplant teams, and used transplant center. The formulated questions were forwarded to all members and recommendations were constructed after an extensive literature review selecting articles with the highest degree of evidence. RESULTS: Guidelines were developed in the form of questions reflecting frequent experiences in clinical intensive care practices. The main questions were: Is there an optimal interval for keeping organs of deceased donors viable? What actions are considered essential for maintaining deceased donors in this period? What are the limits of body temperature? How should the patient be warmed? Which laboratory tests should be performed? What is the collection interval? What are the limits in the laboratory and the capture scenario? What are the limits of blood pressure? When and how should one use catecholamines? CONCLUSIONS: This pioneer project involved a multidisciplinary team working in organ transplantation seeking to provide treatment guidance to increase the number of viable organs from deceased adult donors.


Subject(s)
Brain Death , Critical Care/standards , Organ Transplantation/standards , Tissue Donors/supply & distribution , Tissue and Organ Harvesting/standards , Tissue and Organ Procurement/standards , Adult , Biomarkers/blood , Blood Pressure , Blood Pressure Determination/standards , Blood Volume , Body Temperature , Brain Death/blood , Brain Death/diagnosis , Brain Death/physiopathology , Brazil , Carbon Dioxide/blood , Cardiotonic Agents/therapeutic use , Echocardiography/standards , Erythrocyte Transfusion/standards , Evidence-Based Medicine , Fluid Therapy/standards , Humans , Intracranial Pressure , Lactic Acid/blood , Oxygen/blood , Rewarming/standards , Time Factors , Tissue Survival , Vasoconstrictor Agents/therapeutic use
7.
Transplant Proc ; 44(8): 2348-51, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23026590

ABSTRACT

BACKGROUND: Conversion to sirolimus (SRL)-based immunosuppression in renal transplant recipients is an alternative for chronic allograft dysfunction (CAD), cancer and viral infections. We sought to analyze the indications for and safety and efficacy of conversion to SRL among renal transplant patients. METHODS/MATERIALS: We examined a retrospective cohort, using medical records of renal transplant recipients >18 years old who had their immunosuppressive regimen converted to a SRL-based treatment. Data analysis included the indication for conversion, time posttransplant, as well as urine protein and serum creatinine at conversion and 6 months thereafter. The end points included death, graft loss and/or discontinuation of SRL. RESULTS: We included 112 patients in this series who had indications for conversion: fungal, polyomavirus, or cytomegalovirus infection (n = 32), CAD (n = 30), cancer (n = 21), immunologic (n = 3), and other reasons (n = 26). Changes in immunosuppression were performed at 41 ± 57 months posttransplant or later in cancer patients. SRL was discontinued in 9 patients owing to adverse events such as edema, proteinuria, mucositis, or pneumonitis. Graft loss was observed in 19 patients, and death in 6. In 87 patients with functioning grafts, protein/creatinine ratios increased from 0.28 ± 0.03 (conversion) to 0.63 ± 0.09 (after 6 months; P < .001). Serum creatinine decreased from 2.24 ± 0.13 (conversion) to 1.89 ± 0.75 mg/dL (after 6 months; P < .001). Graft survival was 88% at 1 and 80% at 3 years after conversion. CONCLUSION: In, SRL was well tolerated; conversion to SRL improved graft function with a slight increase in proteinuria.


Subject(s)
Graft Rejection/prevention & control , Graft Survival/drug effects , Immunosuppressive Agents/administration & dosage , Kidney Transplantation/immunology , Sirolimus/administration & dosage , Biomarkers/blood , Chi-Square Distribution , Creatinine/blood , Drug Substitution , Graft Rejection/blood , Graft Rejection/immunology , Humans , Immunosuppressive Agents/adverse effects , Kaplan-Meier Estimate , Kidney Transplantation/adverse effects , Proteinuria/etiology , Proteinuria/prevention & control , Retrospective Studies , Risk Assessment , Risk Factors , Sirolimus/adverse effects , Time Factors , Treatment Outcome
8.
Transplant Proc ; 44(8): 2366-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23026594

ABSTRACT

INTRODUCTION: After renal transplantation recovery in nutritional status occurs during the first year. We assessed the changes in nutritional status after transplantation in 145 transplant recipients (94 males, 51 females). METHODS: Patients were evaluated immediately after renal transplant (baseline data) and at 6 months' follow-up. Analysis included body mass index (BMI), body composition (skin fold and arm circumference), and estimated body composition (calculated percent of fat, arm circumference, arm muscle circumference, and arm muscle area). Other data obtained from medical records included renal function (MDRD) serum albumin and lipid profile. RESULTS: At baseline evaluation (21 ± 15 days posttransplant), mean BMI was 23.9 ± 3.9 kg/m(2), serum albumin was 3.7 ± 0.7 g/dL, and lipid profile showed (cholesterol 158.5 ± 52.7 mg% and triglycerides 135.9 ± 91.8 mg%. Body composition analysis showed better adaptation of muscle mass in females [AC (91 ± 10.2 × 98 ± 14.6; male × female, P < .05) arm muscle circumference (92.6 ± 1.4 × 102.3% ± 2.9%, male × female, P < .05) and arm muscle area (87.1 ± 22.3 × 105.5% ± 25.9%, male × female, P < .05)]. Body fat was above the recommended levels in 80% of patients, especially females. After 6 months we divided the groups according to BMI, observing better renal function in the normal weight group compared with obese subjects (60 ± 17.2 × 39.5 ± 19.8 mL/min MDRD, P < .05), despite comparable estimated glomerular filtration rate at baseline. CONCLUSION: The nutritional assessment of patients with end-stage renal disease early after renal transplantation, showed inadequate body composition, with increased fat and reduced lean body mass. The lower glomerular filtration rate after 6 months may be attributed to relatively inadequate renal mass or to obesity-induced hyperfiltration.


Subject(s)
Body Composition , Kidney Failure, Chronic/surgery , Kidney Transplantation/adverse effects , Nutritional Status , Obesity/diagnosis , Adiposity , Adult , Biomarkers/blood , Body Mass Index , Brazil/epidemiology , Female , Glomerular Filtration Rate , Humans , Kidney Failure, Chronic/epidemiology , Kidney Failure, Chronic/physiopathology , Lipids/blood , Male , Middle Aged , Nutrition Assessment , Obesity/blood , Obesity/epidemiology , Obesity/physiopathology , Prevalence , Prospective Studies , Serum Albumin/metabolism , Serum Albumin, Human , Skinfold Thickness , Time Factors , Treatment Outcome
9.
Transplant Proc ; 44(8): 2394-6, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23026603

ABSTRACT

BACKGROUND: Polyomavirus BK (BKV) is currently considered one of the most important infectious diseases in kidney transplants recipients. The prevalence of decoy cells (viral containing shed urothelial cells) in these patients varies between 20% and 60%. Of decoy-positive patients, 1%-8% develop BKV nephropathy, a finding that may be associated with graft failure in up to 80% of affected individuals. METHODS: Decoy cells cytology is an easily performed and inexpensive assay useful for poliomavirus infection screening. Data on the prevalence of decoy cells in simultaneous pancreas-kidney or isolated pancreas recipients remains largely unreported. In the present study, we evaluated 221 patients ≥18 years old with >1 month follow-up after transplantation who had attended the outpatient clinic between September and December 2006. RESULTS: The total prevalence of decoy cells was 16% (16.9% in kidney recipients, 5.9% in simultaneous kidney-pancreas recipients and 20% in pancreas alone recipients). There were no differences between patients with either positive or negative urinary cytology for decoy cells, regarding demographic (gender, age, race) or clinical (time posttransplantation, donor type [deceased vs living donation], and presence of delayed graft function or rejection, other associated viral infections and type of immunosuppressive drugs variables.


Subject(s)
BK Virus/isolation & purification , Kidney Transplantation/adverse effects , Pancreas Transplantation/adverse effects , Polyomavirus Infections/diagnosis , Tumor Virus Infections/diagnosis , Urothelium/virology , Adolescent , Adult , Aged , Brazil , Cross-Sectional Studies , Delayed Graft Function/virology , Female , Graft Rejection/virology , Humans , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Polyomavirus Infections/epidemiology , Polyomavirus Infections/urine , Polyomavirus Infections/virology , Predictive Value of Tests , Prevalence , Time Factors , Treatment Outcome , Tumor Virus Infections/epidemiology , Tumor Virus Infections/urine , Tumor Virus Infections/virology , Urinalysis , Urine/cytology , Urine/virology , Young Adult
10.
Transplant Proc ; 44(8): 2452-4, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23026618

ABSTRACT

INTRODUCTION: Renal insufficiency can be associated with poor long-term survival of liver transplant recipients. OBJECTIVE: The objective of this study was to study renal insufficiency observed pretransplantation and its long-term impact after liver transplantation. METHODS: We analyzed retrospectively an electronic database collected prospectively including transplant records from June 1994 to October 2010 using piggyback venous reconstruction. The exclusion criteria were chronic kidney disease, acute hepatic failure, children up to 12 years of age, and retransplantations. Renal insufficiency was defined by the creatinine clearance (CCr) calculated using the Cockcroft-Gault method. Patients were distributed into 3 groups: CCr >90, between 90 and 60, and >60 mL/min/1.73 m(2). The survival rate was calculated using the Kaplan-Meier method and proportional hazards Cox regression analysis using death and CCr as stratifying variables evaluated predictive factors for survival. The groups were compared using the Kruskal-Wallis test with significant differences at P < .05. RESULTS: Among the 305 patients those who showed preoperative and postoperative CCR of >90 were 187/59.9% and 82/26.3%, 60 to 90 were 77/24.7% and 74/23.7%, or <60 mL/min/1.73 m(2) were (41/13.1% and 149 (47.7%). Patients with preoperative CCr <60 mL/min/1.73 m(2) showed worse short- and long-term survivals as well as the longest intensive care unit and hospital stays (P = .034). The only predictive donor factor was age older than 40 years namely, the greatest hemotransfusion needs and postoperative liver and renal dysfunction (Chi square = 100.6064; P = .00001). The area under the curve (AUC) obtained using an receiver operating characteristic (ROC) analysis was 0.563 (95% CI 0.498-0.627) with a cut off of 30.25. CONCLUSION: Pre-liver transplantation renal insufficiency seemed to be a predictive factor for long-term survival.


Subject(s)
Creatinine/blood , Liver Diseases/surgery , Liver Transplantation/mortality , Renal Insufficiency/diagnosis , Adult , Age Factors , Biomarkers/blood , Chi-Square Distribution , Female , Humans , Kaplan-Meier Estimate , Kidney Function Tests , Liver Diseases/complications , Liver Diseases/mortality , Liver Transplantation/adverse effects , Male , Middle Aged , Proportional Hazards Models , ROC Curve , Renal Insufficiency/blood , Renal Insufficiency/complications , Renal Insufficiency/mortality , Retrospective Studies , Risk Assessment , Risk Factors , Severity of Illness Index , Survival Rate , Time Factors , Treatment Outcome
11.
Transplant Proc ; 41(3): 849-51, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19376369

ABSTRACT

UNLABELLED: Delayed graft function (DGF), a frequent complication after kidney transplantation, occurs among about 60% of recipients of kidneys from deceased donors. DGF has a multifactorial etiology. It is characterized by acute tubular necrosis (ATN) upon biopsy. In this study we sought to identify among a group of recipients of kidneys from deceased donors, the incidence, risk factors, and impacts on patient and graft survivals of DGF. MATERIALS AND METHODS: We retrospectively analyzed medical records from renal transplant recipients aged >18 years who received a deceased donor kidney graft between January 2003 and December 2006. Kidneys lost during the first week posttransplantation were excluded from this series. RESULTS: Among 165 transplants, 111 (67%) displayed DGF, defined as the need for dialysis during the first week posttransplantation. The incidence of DGF was higher among patients with a cold ischemia time (CIT) > 24 hours: 85% vs 60%, DGF vs no DGF (P < .05), as well as for grafts from older donors. After 1-year follow-up, the DGF group showed worse graft function (serum creatinine 1.6 +/- 0.7 vs 1.3 +/- 0.4 mg/dL; P < .05) as well as a greater incidence of graft loss. CONCLUSION: Prolonged cold ischemia and older donor age were associated with a greater incidence of DGF in this series, leading to prolonged hospitalization, increased risk for an acute rejection episode, and reduced graft function and survival after 1 year.


Subject(s)
Kidney Transplantation/physiology , Kidney Tubules/pathology , Adult , Cadaver , Follow-Up Studies , Graft Survival/physiology , Humans , Ischemia , Kidney Diseases/classification , Kidney Diseases/surgery , Kidney Transplantation/pathology , Length of Stay , Middle Aged , Necrosis , Postoperative Complications/epidemiology , Postoperative Complications/pathology , Retrospective Studies , Risk Factors , Sex Characteristics , Time Factors , Tissue Donors/statistics & numerical data , Young Adult
12.
Transplant Proc ; 41(3): 883-4, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19376379

ABSTRACT

UNLABELLED: Renal transplant recipients receiving immunosuppression show an increased risk for developing opportunistic infections, such as tuberculosis (TB). TB represents the major cause of morbidity and mortality in the world, mainly in underdeveloped countries. The aim of this study was to analyze the incidence of TB and its presentation among renal transplant recipients over 20 years. PATIENTS AND METHODS: This retrospective analysis included medical records of renal transplant recipients from January 1984 to April 2007. RESULTS: Among 1342 renal transplant recipients, 31 received treatment for TB due to clinical disease (n = 23) or prophylaxis (n = 8). The overall incidence of TB was 1.71%, which was diagnosed at 53 +/- 49 months posttransplantation. The indications for TB prophylaxis were a previous history of TB (n = 6) or direct contact with a TB carrier (n = 1). The most common clinical presentation was extrapulmonary (n = 13). The classical treatment was effective in 16 cases. However, 7 cases of resistant TB required ethambutol added to therapy. Adverse events of treatment included liver toxicity (n = 1) and peripheral neuropathy (n = 1). Three patients died due to TB-related complications. Graft loss was observed in 3 patients after cessation of TB treatment. None of the patients on prophylaxis developed clinical disease. CONCLUSIONS: TB incidence was significantly greater among renal transplant recipients compared with the local population, with a higher incidence of extrapulmonary disease. TB prophylaxis in selected cases was effective, avoiding new infections.


Subject(s)
Antitubercular Agents/therapeutic use , Ethambutol/therapeutic use , Kidney Transplantation/adverse effects , Tuberculosis/epidemiology , Biopsy , Brazil/epidemiology , Humans , Incidence , Recurrence , Registries , Retrospective Studies , Tuberculosis/pathology
13.
Transplant Proc ; 40(3): 746-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18455005

ABSTRACT

BACKGROUND: Renal transplantation is considered a safe procedure for patients with systemic lupus erythematosus (SLE). However, the recurrence of disease and its impact on graft survival remains controversial. METHODS: To analyze the presence of lupus serology activity during dialysis and its impact on lupus recurrence after transplantation, we performed a retrospective analysis of 23 lupus patients who received 26 kidney transplantations. RESULTS: Twenty-three patients received 26 renal transplantations from 1984 to 2003. Twelve patients presented pretransplant lupus activity (low complement and ANA > 1/40), without correlation with length of dialysis, but associated with proliferative glomerulonephritis (class IV) pretransplant. Among 26 grafts, 6 were lost in the first 6 months posttransplant. Among the remaining 20 functioning grafts, low complement activity occurred in 8, being associated with recurrence of immune deposits in 3 cases. Analysis of lupus activity showed that only one patient with a normal complement level posttransplant presented SLEDAI > 4, associated with persistent proteinuria and a graft biopsy without immune deposits. Graft survival was reduced in the presence of low complement posttransplantation. CONCLUSION: Low complement levels after renal transplantation, in association with proteinuria may be considered to be a risk factor for recurrence of immune deposits, with a negative impact on graft survival.


Subject(s)
Complement System Proteins/metabolism , Graft Survival/physiology , Kidney Transplantation/adverse effects , Kidney Transplantation/physiology , Lupus Erythematosus, Systemic/epidemiology , Postoperative Complications/epidemiology , Biomarkers/blood , Humans , Kidney Failure, Chronic/surgery , Recurrence , Time Factors
14.
Transplant Proc ; 40(3): 749-51, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18455006

ABSTRACT

An estimated 350 million persons worldwide are chronically infected with hepatitis B virus (HBV). Immunosuppression after renal transplantation seems to enhance viral replication and increase the risk of developing cirrhosis and hepatocellular carcinoma. This retrospective study was performed to assess the prevalence among and serological status of HBV infection after renal transplantation at a single university Brazilian center. Thirty six (4.2%) patients among 850 kidney recipients showed positive HBsAg for more than 6 months; 31 were hepatitis B surface antigen (HBsAg) positive at transplantation. Of the 15 hepatitis B e antigen (HbeAg) positive patients, six had spontaneous HBeAg seroconversion and three also had HBsAg clearance. An additional two showed HBeAg clearance with Lamivudine without seroconversion. Among 15 HBeAg-negative patients, three developed HBeAg reversion with no elevation of alanine transferase (ALT) levels and one had HBsAg clearance. Only one patient had acute exacerbation of hepatitis B (ALT > 20 times normal range) but remained HbeAg negative. During follow-up, five patients became HBsAg positive; two reactivations of resolved hepatitis B, two with previous anti-HBS induced by vaccination, and one with no serological marker for HBV. Lamivudine was prescribed for 16 patients, two of whom had HbeAg clearance without seroconversion and five who developed viral resistance to Lamivudine after a mean of 29.2 months. No hepatocellular carcinoma or deaths related to hepatitis B were seen in this group. In summary, prevalence of HBV in kidney transplant patients was 4.2%. Immunosuppression after renal transplantation in HBV infection led to an increased risk of liver complications and changes in HBV serological status.


Subject(s)
Hepatitis B e Antigens/blood , Hepatitis B/blood , Kidney Transplantation/adverse effects , Lamivudine/therapeutic use , Antiviral Agents/therapeutic use , Hepatitis B/drug therapy , Hepatitis B/epidemiology , Humans , Postoperative Complications/epidemiology , Postoperative Complications/virology , Prevalence , Retrospective Studies , Treatment Outcome
15.
Transplant Proc ; 40(3): 764-6, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18455010

ABSTRACT

UNLABELLED: Posttransplant diabetes mellitus (PTDM) is common post transplantation and is associated with tacrolimus (TAC) and steroid therapy. The aim of the present study was to analyze the incidences of PTDM and associated risk factors. METHODS: We selected renal transplant recipients treated with TAC, mycophenolate mofetil (MM), and steroids. Exclusion criteria were recipients <18 years old, history of diabetes, recipients of kidney/pancreas, and/or those receiving cyclosporine or sirolimus. PTDM was defined as glucose >126 mg/dL, with or without drug therapy. RESULTS: Among 67 patients who fulfilled the inclusion criteria, 18 (26.8%) developed PTDM within 2 months of transplantation. Compared with normal glucose patients, the PTDM group was older, male, received a kidney from deceased donors, and showed higher pretransplant glucose levels. No differences were noticed in renal function or daily dose of TAC or steroids. However, TAC trough levels in the first month were higher among the PTDM group, despite the lower dose per kilogram. After 1 year of follow-up, weight gain as well as daily TAC per kilogram dose was less among PTDM patients. Analysis of potential risk factors showed a higher incidence of hepatitis C virus infection in the PTDM group, as well as a higher frequency of HLA DR13. CONCLUSION: The incidence of PTDM diagnosed in the early posttransplant period in the present series was 26.8%. Risk factors included older age, male gender, recipients of kidneys from deceased donors, hepatitis C virus infection, higher pretransplant glucose levels, and higher TAC trough levels during the first month posttransplant.


Subject(s)
Diabetes Mellitus/epidemiology , Kidney Transplantation/adverse effects , Adult , Female , Follow-Up Studies , Humans , Hyperglycemia/epidemiology , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/immunology , Male , Middle Aged , Postoperative Complications/epidemiology , Risk Factors , Tacrolimus/blood , Tacrolimus/therapeutic use , Time Factors , Weight Gain
16.
Transplant Proc ; 40(3): 767-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18455011

ABSTRACT

UNLABELLED: Renal transplant recipients have an increased risk of malignancies, especially nonmelanoma skin cancers, compared with the normal population. The aim of the present study was to analyze the incidence of skin malignancies in a setting of renal transplant recipients over 20 years follow-up. PATIENTS AND METHODS: This retrospective analysis of medical records included posttransplant patients with biopsy-proven skin cancer. Recipients of pancreas kidney transplants or with suspected but not biopsy-proven skin malignancy were excluded from this series. RESULTS: Among 1300 renal transplant recipients from January 1984 to December 2006, 33 (2.5%) were diagnosed with skin malignancies during follow-up. The majority of patients were men (70.2%), of white race (97%), and with a mean posttransplant follow-up of 65 months. The most frequent skin cancer was squamous cell carcinoma (46.2%), in single or multiple lesions (50% each group). Basal cell carcinoma was diagnosed in seven patients; most presented as a single lesion (71.3%). Eight patients presented with more than one histologic type of skin cancer; most frequently squamous and basal cell carcinomas. Kaposi sarcoma was diagnosed in four patients, one of whom also had a basal cell carcinoma. CONCLUSION: The incidence of skin malignancies in this series was 2.5%. The most frequent tumor was squamous cell carcinoma, isolated or in association with basal cell carcinoma. An higher frequency was observed in white male patients, at a mean follow-up of 5 years posttransplantation.


Subject(s)
Kidney Transplantation/adverse effects , Postoperative Complications/epidemiology , Skin Neoplasms/epidemiology , Adolescent , Adult , Brazil/epidemiology , Female , Follow-Up Studies , Humans , Male , Registries , Retrospective Studies , Time Factors
17.
Clin Transplant ; 22(5): 609-16, 2008.
Article in English | MEDLINE | ID: mdl-18459998

ABSTRACT

Heme oxygenase-1 (HO-1) has a microsatellite polymorphism based on the number of guanosine-thymidine nucleotide repeats (GT) repeats that regulates expression levels and could have an impact on organ survival post-injury. We correlated HO-1 polymorphism with renal graft function. The HO-1 gene was sequenced (N = 181), and the allelic repeats were divided into subclasses: short repeats (S) (<27 repeats) and long repeats (L) (>/=27 repeats). A total of 47.5% of the donors carried the S allele. The allograft function was statistically improved six months, two and three yr after transplantation in patients receiving kidneys from donors with an S allele. For the recipients carrying the S allele (50.3%), the allograft function was also better throughout the follow-up, but reached statistical significance only three yr after transplantation (p = 0.04). Considering only those patients who had chronic allograft nephropathy (CAN; 74 of 181), allograft function was also better in donors and in recipients carrying the S allele, two and three yr after transplantation (p = 0.03). Recipients of kidney transplantation from donors carrying the S allele presented better function even in the presence of CAN.


Subject(s)
Graft Survival/genetics , Heme Oxygenase-1/genetics , Kidney Transplantation , Tissue Donors , Adult , Case-Control Studies , Dinucleotide Repeats/genetics , Female , Gene Frequency , Humans , Longitudinal Studies , Male , Middle Aged , Polymorphism, Genetic/genetics , Prognosis , Promoter Regions, Genetic/genetics , Young Adult
18.
Transplant Proc ; 39(2): 429-31, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17362748

ABSTRACT

AIM: The influence of panel-reactive antibody level (%PRA) on crossmatch results was evaluated among 866 patients on the waiting list for cadaveric renal allografting from January 2001 to August 2005. We evaluated the results for 124 potential donors for a kidney, including 2008 crossmatches. Four hundred eighteen patients were tested against only 1 donor. METHODS: Serum samples were screened for anti-HLA antibodies using immunoglobulin (Ig)G enzyme-linked immunosorbent assay (ELISA) PRA kit and the %PRA of the most reactive sample (peak) was used for patient stratification, according to sensitization level. Crossmatches were performed on fresh donor T lymphocytes from peripheral lymph nodes, using classical and anti-human-globulin enhanced complement-dependent cytotoxicity (CDC-T) methods. The tests were performed using peak and current patient sera before and after dithiothreitol treatment. The crossmatch was assumed to be negative when no reactivity was observed in all tests. RESULTS: The incidences of positive crossmatch were as follows: 72.3%, 14.6%, and 7.2%, among patients with PRA >50%, PRA

Subject(s)
Histocompatibility Testing/methods , Isoantibodies/immunology , Kidney Transplantation/immunology , ABO Blood-Group System/immunology , Cadaver , Graft Rejection/immunology , Humans , T-Lymphocytes/immunology , Tissue Donors , Waiting Lists
19.
Transplant Proc ; 39(2): 457-9, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17362758

ABSTRACT

UNLABELLED: Renal fibrosis is a hallmark of end-stage renal diseases and of chronic allograft nephropathy (CAN). Rapamycin, besides its action through blockade of lymphocyte proliferation, also has antiproliferative, antiviral, and antitumor actions. Its use in clinical in patients with CAN has recently been advocated. OBJECTIVES: Our goal was to evaluate the effect of rapamycin in an established model of renal fibrosis, unilateral ureteral obstruction. MATERIALS AND METHODS: C57BL/6 mice were divided into two groups, treated or not with daily doses of rapamycin (0.2 mg/kg) beginning on day-1. The obstruction was performed as day 0. Blood and kidney tissues were collected at 1, 4, 7, and 14 days after the surgery to quantify bone morphogenic protein (BMP)-7 and transforming growth factor (TGF)-beta mRNA by real time PCR. RESULTS: Daily treatment with rapamycin caused a significant reduction in serum creatinine at day 1 (0.57 +/- 0.03 vs 0.95 +/- 0.15 mg/dL, P = .002) and at day 14 (0.56 +/- 0.04 vs 0.73 +/- 0.07 mg/dL, P = .040). This profile was corroborated by histological morphometric analyses showing less fibrosis at day 14. However, rapamycin surprisingly induced an upregulation of TGF-beta at day 4 (3.05 +/- 0.46 vs 1.85 +/- 0.41, P = .006) and at day 7 (6.33 +/- 0.55 vs 4.97 +/- 0.38, P = .024) with a reduced expression by day 14 (4.03 +/- 1.07 vs 7.89 +/- 0.83, P < .001). Surprisingly, rapamycin also promoted an increment in BMP-7, completely reversing the ratio of TGF-beta to BMP-7, allowing a more protective phenotype. CONCLUSION: Rapamycin slightly ameliorated the renal dysfunction and, at later time points, induced less fibrosis and less decrease in the TGF-beta to BMP-7 ratio.


Subject(s)
Fibrosis/chemically induced , Kidney/pathology , Sirolimus/adverse effects , Animals , Bone Morphogenetic Protein 7 , Bone Morphogenetic Proteins/genetics , Creatinine/blood , Disease Models, Animal , Disease Progression , Immunosuppressive Agents/adverse effects , Kidney/drug effects , Kidney Failure, Chronic/pathology , Kidney Function Tests , Male , Mice , Mice, Inbred C57BL , RNA, Messenger/genetics , Transforming Growth Factor beta/genetics
20.
J Hosp Infect ; 63(2): 117-23, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16517007

ABSTRACT

A prospective cohort study was conducted from January 2000 to December 2001 to determine the rate of bacterial nosocomial infections in renal transplant recipients. The patients were divided into two groups according to the origin of the allograft, namely deceased or living related donors. One hundred and sixty-three renal transplant recipients were reviewed during hospitalization; 110 (67.5%) kidneys were from deceased donors and 53 (32.5%) kidneys were from living related donors. The median length of hospitalization was 12 days for transplants from living related donors and 26 days for transplants from deceased donors (P<0.0001). Twenty-one (39.6%) recipients of kidneys from living related donors and 68 (61.8%) recipients of kidneys from deceased donors had bacterial nosocomial infectious episodes (P=0.019). The post-transplant nosocomial infections diagnosed during hospitalization included urinary tract infections (UTIs) (44.8%), surgical site infections (SSIs) (11%), pneumonia (6.1%), catheter-related bloodstream infections (4.2%) and others (1.8%). Risk factors for UTI included: recipient of kidney from a deceased donor, substitution of the initial immunosuppressive regimen, duration of urinary bladder catheterization, and length of hospitalization before the infection. Six Enterobacter cloacae strains with multiple resistances to antibiotics were identified in UTIs, and hospital dissemination was documented using molecular typing. UTI was the single most important hospital infection and was significantly higher in recipients of kidneys from deceased donors (P=0.001).


Subject(s)
Bacterial Infections/epidemiology , Cross Infection/epidemiology , Kidney Transplantation/adverse effects , Surgical Wound Infection/epidemiology , Urinary Tract Infections/epidemiology , Adolescent , Adult , Aged , Bacterial Infections/microbiology , Bacterial Infections/prevention & control , Brazil/epidemiology , Cross Infection/microbiology , Cross Infection/prevention & control , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Prospective Studies , Risk Factors , Surgical Wound Infection/microbiology , Surgical Wound Infection/prevention & control , Urinary Tract Infections/microbiology , Urinary Tract Infections/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...